Therefore, we speculate that the inconsistency of PCMT1 mRNA and protein expression in breast cancer stems from the inhibition of posttranslational modification and other processes in breast cancer, resulting in lower protein expression levels than normal tissues. Here, PCMT1 is linked to breast carcinoma.